Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aeterna Zentaris Inc

+ Add to Watchlist

AEZS:US

0.6400 USD 0.0222 3.59%

As of 12:39:49 ET on 02/27/2015.

Snapshot for Aeterna Zentaris Inc (AEZS)

Open: 0.6118 Day's Range: 0.6118 - 0.6692 Volume: 945,607
Previous Close: 0.6178 52wk Range: 0.4800 - 1.5400 1-Yr Rtn: -48.80%

Stock Chart for AEZS

No chart data available.
  • AEZS:US 0.6400
  • 1D
  • 1M
  • 1Y
0.6178
Interactive AEZS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AEZS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.5150
Est. PEG Ratio -
Market Cap (M USD) 41.84
Shares Outstanding (M) 65.51
30 Day Average Volume 475,504
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AEZS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AEZS

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval.

David A DoddPresident/CEODennis TurpinSenior VP/CFO
Philip A TheodoreSenior VP/CAO/Secy/Gen CnslJude DingesSenior VP/Chief Commercial Ofcr
More Company Profile & Key Executives for AEZS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil